Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-45.44	67.50	123.72
Graham Fair Price	42.21	1.44	1.01
PEG	-6.09	0.07	-0.08
Price/Book	-1.95	0.73	0.74
Price/Cash Flow	-89.25	-30.61	284.74
Prices/Earnings	-50.97	7.46	15.21
Price/Sales	-49.13	23.06	45.32
Price/FCF	-89.25	-30.61	284.74
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.97	0.74	0.74
Operating Margin	-3.25	0.54	0.56
ROA	100.00	0.02	< 0.005
ROE	0.01	0.02	100.00
ROIC	< 0.005	0.01	86.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	-0.04	-99.55
Dividends QOQ	-0.41	1.01	145.78
EBIT QOQ	-0.08	0.86	990.03
EPS QOQ	1.94	1.01	-47.80
FCF QOQ	-0.80	-10.12	-1160.89
Revenue QOQ	-0.49	0.93	90.19
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-28.33	-15.10	46.68
Days Sales Outstanding (DSO)	24.45	92.18	277.08
Inventory Turnover	-3.18	-5.96	-87.54
Debt/Capitalization	0.31	0.31	-0.12
Quick Ratio	1.17	1.17	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.93	1.94	0.56
Cash	0.08	0.08	-2.71
Capex	< 0.005	0.06	208261.84
Free Cash Flow	< 0.005	-0.05	817.07
Revenue	0.03	0.06	93.81
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.15	1.15	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	43.48	25.32	-41.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating